TabletsTablets
Schedule H1 (Prescription Required - Habit Forming Warning)Anxiolytics & SedativesCode: 764

Etizolam Tablets 0.5mg

Generic Formulation:Etizolam Tablets IP 0.5mg
Pack Size:10's
Common Commercial Brand Equivalents:Market reference only
Jan Aushadhi MRP
₹10.21
Brand Estimate*
₹114.3
Estimated Savings:₹104.09 (91% saved)
Find a Kendra Near You
*Statutory price across 21,118 listed Kendras
Clinical InformationReport Error

Clinical Overview

Etizolam is a thienodiazepine derivative structurally related to benzodiazepines. It acts as a potent full agonist at the GABAA receptor, producing significant anxiolytic, sedative-hypnotic, anticonvulsant, and muscle-relaxant actions with 6- to 10-fold higher potency than diazepam. Indicated for short-term management of generalized anxiety disorder, panic disorder, and insomnia associated with anxiety.

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 764.Report inaccuracy

Usage Guidelines

Take orally with water, with or without meals. Strictly adhere to short-term therapy limits (typically 2-4 weeks). Do not exceed prescribed doses. Discontinue by gradual tapering.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Drowsiness, sedation, muscle weakness, ataxia, headache, dry mouth. Rare/Severe: Blepharospasm, dependence, tolerance, severe withdrawal delirium, and respiratory depression.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

High risk of physical dependence and abuse. Contraindicated in myasthenia gravis, severe respiratory failure, and acute angle-closure glaucoma. Never combine with alcohol or opioids.

Schedule H1 (Prescription Required - Habit Forming Warning)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.